Chapter/Section Purchase

Leave This Empty:

Global Intermittent Claudication Market Insights, Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intermittent Claudication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Medication Therapies
1.2.3 Revascularization
1.3 Market by Application
1.3.1 Global Intermittent Claudication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Healthcare
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Intermittent Claudication Market Perspective (2017-2028)
2.2 Intermittent Claudication Growth Trends by Region
2.2.1 Intermittent Claudication Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Intermittent Claudication Historic Market Size by Region (2017-2022)
2.2.3 Intermittent Claudication Forecasted Market Size by Region (2023-2028)
2.3 Intermittent Claudication Market Dynamics
2.3.1 Intermittent Claudication Industry Trends
2.3.2 Intermittent Claudication Market Drivers
2.3.3 Intermittent Claudication Market Challenges
2.3.4 Intermittent Claudication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intermittent Claudication Players by Revenue
3.1.1 Global Top Intermittent Claudication Players by Revenue (2017-2022)
3.1.2 Global Intermittent Claudication Revenue Market Share by Players (2017-2022)
3.2 Global Intermittent Claudication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intermittent Claudication Revenue
3.4 Global Intermittent Claudication Market Concentration Ratio
3.4.1 Global Intermittent Claudication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intermittent Claudication Revenue in 2021
3.5 Intermittent Claudication Key Players Head office and Area Served
3.6 Key Players Intermittent Claudication Product Solution and Service
3.7 Date of Enter into Intermittent Claudication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intermittent Claudication Breakdown Data by Type
4.1 Global Intermittent Claudication Historic Market Size by Type (2017-2022)
4.2 Global Intermittent Claudication Forecasted Market Size by Type (2023-2028)
5 Intermittent Claudication Breakdown Data by Application
5.1 Global Intermittent Claudication Historic Market Size by Application (2017-2022)
5.2 Global Intermittent Claudication Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Intermittent Claudication Market Size (2017-2028)
6.2 North America Intermittent Claudication Market Size by Type
6.2.1 North America Intermittent Claudication Market Size by Type (2017-2022)
6.2.2 North America Intermittent Claudication Market Size by Type (2023-2028)
6.2.3 North America Intermittent Claudication Market Share by Type (2017-2028)
6.3 North America Intermittent Claudication Market Size by Application
6.3.1 North America Intermittent Claudication Market Size by Application (2017-2022)
6.3.2 North America Intermittent Claudication Market Size by Application (2023-2028)
6.3.3 North America Intermittent Claudication Market Share by Application (2017-2028)
6.4 North America Intermittent Claudication Market Size by Country
6.4.1 North America Intermittent Claudication Market Size by Country (2017-2022)
6.4.2 North America Intermittent Claudication Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Intermittent Claudication Market Size (2017-2028)
7.2 Europe Intermittent Claudication Market Size by Type
7.2.1 Europe Intermittent Claudication Market Size by Type (2017-2022)
7.2.2 Europe Intermittent Claudication Market Size by Type (2023-2028)
7.2.3 Europe Intermittent Claudication Market Share by Type (2017-2028)
7.3 Europe Intermittent Claudication Market Size by Application
7.3.1 Europe Intermittent Claudication Market Size by Application (2017-2022)
7.3.2 Europe Intermittent Claudication Market Size by Application (2023-2028)
7.3.3 Europe Intermittent Claudication Market Share by Application (2017-2028)
7.4 Europe Intermittent Claudication Market Size by Country
7.4.1 Europe Intermittent Claudication Market Size by Country (2017-2022)
7.4.2 Europe Intermittent Claudication Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intermittent Claudication Market Size (2017-2028)
8.2 Asia-Pacific Intermittent Claudication Market Size by Type
8.2.1 Asia-Pacific Intermittent Claudication Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Intermittent Claudication Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Intermittent Claudication Market Share by Type (2017-2028)
8.3 Asia-Pacific Intermittent Claudication Market Size by Application
8.3.1 Asia-Pacific Intermittent Claudication Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Intermittent Claudication Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Intermittent Claudication Market Share by Application (2017-2028)
8.4 Asia-Pacific Intermittent Claudication Market Size by Region
8.4.1 Asia-Pacific Intermittent Claudication Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Intermittent Claudication Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Intermittent Claudication Market Size (2017-2028)
9.2 Latin America Intermittent Claudication Market Size by Type
9.2.1 Latin America Intermittent Claudication Market Size by Type (2017-2022)
9.2.2 Latin America Intermittent Claudication Market Size by Type (2023-2028)
9.2.3 Latin America Intermittent Claudication Market Share by Type (2017-2028)
9.3 Latin America Intermittent Claudication Market Size by Application
9.3.1 Latin America Intermittent Claudication Market Size by Application (2017-2022)
9.3.2 Latin America Intermittent Claudication Market Size by Application (2023-2028)
9.3.3 Latin America Intermittent Claudication Market Share by Application (2017-2028)
9.4 Latin America Intermittent Claudication Market Size by Country
9.4.1 Latin America Intermittent Claudication Market Size by Country (2017-2022)
9.4.2 Latin America Intermittent Claudication Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intermittent Claudication Market Size (2017-2028)
10.2 Middle East & Africa Intermittent Claudication Market Size by Type
10.2.1 Middle East & Africa Intermittent Claudication Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Intermittent Claudication Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Intermittent Claudication Market Share by Type (2017-2028)
10.3 Middle East & Africa Intermittent Claudication Market Size by Application
10.3.1 Middle East & Africa Intermittent Claudication Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Intermittent Claudication Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Intermittent Claudication Market Share by Application (2017-2028)
10.4 Middle East & Africa Intermittent Claudication Market Size by Country
10.4.1 Middle East & Africa Intermittent Claudication Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Intermittent Claudication Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 I'ROM GROUP(DNAVEC Corporation)
11.1.1 I'ROM GROUP(DNAVEC Corporation) Company Details
11.1.2 I'ROM GROUP(DNAVEC Corporation) Business Overview
11.1.3 I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Introduction
11.1.4 I'ROM GROUP(DNAVEC Corporation) Revenue in Intermittent Claudication Business (2017-2022)
11.1.5 I'ROM GROUP(DNAVEC Corporation) Recent Developments
11.2 Nuo Therapeutics Inc.
11.2.1 Nuo Therapeutics Inc. Company Details
11.2.2 Nuo Therapeutics Inc. Business Overview
11.2.3 Nuo Therapeutics Inc. Intermittent Claudication Introduction
11.2.4 Nuo Therapeutics Inc. Revenue in Intermittent Claudication Business (2017-2022)
11.2.5 Nuo Therapeutics Inc. Recent Developments
11.3 Kowa Company Ltd.
11.3.1 Kowa Company Ltd. Company Details
11.3.2 Kowa Company Ltd. Business Overview
11.3.3 Kowa Company Ltd. Intermittent Claudication Introduction
11.3.4 Kowa Company Ltd. Revenue in Intermittent Claudication Business (2017-2022)
11.3.5 Kowa Company Ltd. Recent Developments
11.4 LTT Bio-Pharma
11.4.1 LTT Bio-Pharma Company Details
11.4.2 LTT Bio-Pharma Business Overview
11.4.3 LTT Bio-Pharma Intermittent Claudication Introduction
11.4.4 LTT Bio-Pharma Revenue in Intermittent Claudication Business (2017-2022)
11.4.5 LTT Bio-Pharma Recent Developments
11.5 Pluristem Therapeutics Inc.
11.5.1 Pluristem Therapeutics Inc. Company Details
11.5.2 Pluristem Therapeutics Inc. Business Overview
11.5.3 Pluristem Therapeutics Inc. Intermittent Claudication Introduction
11.5.4 Pluristem Therapeutics Inc. Revenue in Intermittent Claudication Business (2017-2022)
11.5.5 Pluristem Therapeutics Inc. Recent Developments
11.6 Nuo Therapeutics, Inc.(Aldagen, Inc.)
11.6.1 Nuo Therapeutics, Inc.(Aldagen, Inc.) Company Details
11.6.2 Nuo Therapeutics, Inc.(Aldagen, Inc.) Business Overview
11.6.3 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Introduction
11.6.4 Nuo Therapeutics, Inc.(Aldagen, Inc.) Revenue in Intermittent Claudication Business (2017-2022)
11.6.5 Nuo Therapeutics, Inc.(Aldagen, Inc.) Recent Developments
11.7 Genovate Biotechnology Co., Ltd.
11.7.1 Genovate Biotechnology Co., Ltd. Company Details
11.7.2 Genovate Biotechnology Co., Ltd. Business Overview
11.7.3 Genovate Biotechnology Co., Ltd. Intermittent Claudication Introduction
11.7.4 Genovate Biotechnology Co., Ltd. Revenue in Intermittent Claudication Business (2017-2022)
11.7.5 Genovate Biotechnology Co., Ltd. Recent Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Intermittent Claudication Introduction
11.8.4 Novartis AG Revenue in Intermittent Claudication Business (2017-2022)
11.8.5 Novartis AG Recent Developments
11.9 ID Pharma Co., Ltd
11.9.1 ID Pharma Co., Ltd Company Details
11.9.2 ID Pharma Co., Ltd Business Overview
11.9.3 ID Pharma Co., Ltd Intermittent Claudication Introduction
11.9.4 ID Pharma Co., Ltd Revenue in Intermittent Claudication Business (2017-2022)
11.9.5 ID Pharma Co., Ltd Recent Developments
11.10 Helixmith Co., Ltd.
11.10.1 Helixmith Co., Ltd. Company Details
11.10.2 Helixmith Co., Ltd. Business Overview
11.10.3 Helixmith Co., Ltd. Intermittent Claudication Introduction
11.10.4 Helixmith Co., Ltd. Revenue in Intermittent Claudication Business (2017-2022)
11.10.5 Helixmith Co., Ltd. Recent Developments
11.11 G. Pohl-Boskamp GmbH & Co. KG
11.11.1 G. Pohl-Boskamp GmbH & Co. KG Company Details
11.11.2 G. Pohl-Boskamp GmbH & Co. KG Business Overview
11.11.3 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Introduction
11.11.4 G. Pohl-Boskamp GmbH & Co. KG Revenue in Intermittent Claudication Business (2017-2022)
11.11.5 G. Pohl-Boskamp GmbH & Co. KG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer